Category: Diagnostics

Diagnostics, Press Releases

Diagnostic Partner 3a Receives BMBF Grant for Infectious Disease Screening Tests

Jun 10, 2020

Vancouver, Canada (June 10, 2020) - XPhyto Therapeutics Corp. (CSE:XPHY / FSE:4XT / OTC:XPHYF) (“XPhyto” or the “Company”) is pleased to announce that its diagnostic...

Continue Reading

Diagnostics, Press Releases

Infectious Disease Oral Dissolvable Biosensor Development

Apr 22, 2020

Vancouver, Canada (April 22, 2020) - XPhyto Therapeutics Corp. (CSE:XPHY / FSE:4XT / OTC:XPHYF) (“XPhyto” or the “Company”) is pleased to announce that further to...

Continue Reading

Diagnostics, Press Releases

COVID-19 Screening Test, Oral Thin Film Biosensor Products and Identification Platform

Apr 20, 2020

Vancouver, Canada (April 20, 2020) - XPhyto Therapeutics Corp. (CSE:XPHY / FSE:4XT / OTC:XPHYF) (“XPhyto” or the “Company”) is pleased to announce that it has...

Continue Reading

Diagnostics, Press Releases

COVID-19 Test and Development Programs Update

Mar 20, 2020

Vancouver, Canada (March 20, 2020) - XPhyto Therapeutics Corp. (CSE:XPHY) (FSE:4XT) (OTC:XPHYF) (“XPhyto” or the “Company”) is pleased to announce updates to its infectious disease...

Continue Reading

Diagnostics, Press Releases

XPhyto Initiates Infectious Disease Programs

Mar 3, 2020

Vancouver, Canada (March 03, 2020) - XPhyto Therapeutics Corp. (CSE:XPHY; FSE:4XT) (“XPhyto” or the “Company”) is pleased to announce that its wholly owned German subsidiary,...

Continue Reading